Lauer, C.; Schreiber, W.; Pollmächer, T.; Holsboer, F.; Krieg, J.-C.: Sleep in schizophrenia; a polysomnographic study on drug-naive patients. Neuropsychopharmacology 16, S. 51 - 60 (1997)

Lechner, C.; Behse, F.: Medianus-SEP zur Prognoseabschätzung des hypoxischen Hirnschadens. EEG-Emg 28, S. 39 - 42 (1997)

Lechner, C.; Behse, F.; Meisenzahl, E.; Brunkhorst, F.: Erholungszeit des Medianus-SEP bei hypoxischem Hirnschaden. EEG-Emg 30, S. 136 - 140 (1997)

Lechner, C.; Dietl, T.; Dirlich, G.; Strian, F.: Topography of habituation profiles of somatosensory evoked potentials. Electroencephalography and Clinical Neurophysiology 103, S. 186 - 187 (1997)

Lezoualc`h, F.; Behl, C.: Activation of a transcription factor NF-χB: a common signal induced by β-amyloid amylin and hydrogen peroxide. Alzheimer's Research 3, S. 43 - 50 (1997)

Linthorst, A. C. E.; Flachskamm, C.; Hopkins, S. J.; Hoadley, M. E.; Labeur, M. S.; Holsboer, F.; Reul, J. M. H. M.: Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral and cytokine responses to a systemic inflammatory challenge. Journal of Neuroscience 17, S. 4448 - 4460 (1997)

Lorenz, M.; Leipert, K.-P.; Wilhelm, H.; Backmund, B.; Prosiegel, M.; Meyer, J.; Zihl, J.: Zerebrale Funktionsstörungen und Blindheit. Teil 1. Augenarzt (1), S. 25 - 28 (1997)

Lorenz, M.; Leipert, K.-P.; Wilhelm, H.; Backmund, B.; Prosiegel, M.; Meyer, J.; Zihl, J.: Zerebrale Funktionsstörungen und Blindheit. Teil 2. Augenarzt (3), S. 93 - 95 (1997)

Ludwig, M.; Johnstone, L. F.; Neumann, I.; Landgraf, R.; Russell, J. A.: Direct hypertonic stimulation of the rat supraoptic nucleus increases c-fos expression in glial cells rather than magnocellular neurones. Cell Tissue Research 287, S. 79 - 90 (1997)

Madeira, M. D.; Andrade, J. P.; Lieberman, A. R.; Sousa, N.; Almeida, O. S. F. X.; Paula-Barbosa, M. M.: Chronic alcohol consumption and withdrawal do not include cell death in the suprachiasmatic nucleus but lead to irreversible depression of peptide immunoreactivity and mRNA levels. Journal of Neuroscience 17, S. 1302 - 1319 (1997)

Marcar, V. L.; Zihl, J.; Cowey, A.: Comparing the visual deficits of a motion blind patient with the visual deficits of monkeys with area MT removed. Neuropsychologia 35, S. 1459 - 1465 (1997)

Modell, S.; Yassouridis, A.; Huber, J.; Holsboer, F.: Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65, S. 216 - 222 (1997)

Montkowski, A.; Holsboer, F.: Intact spatial learning and memory in transgenic mice with reduced BDNF. Neuroreport 8 (1997)

Montkowski, A.; Landgraf, R.; Yassouridis, A.; Holsboer, F.; Schöbitz, B.: Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacology Biochemistry & Behavior 58, S. 329 - 336 (1997)

Montkowski, A.; Poettig, M.; Mederer, A.; Holsboer, F.: Behavioural performance in three substrains of mouse strain 129. Brain Research 762, S. 12 - 18 (1997)

Moosmann, M.; Uhr, M.; Behl, C.: Neuroprotective potential of aromatic alcohols against oxidative cell death. FEBS Letters 413, S. 467 - 472 (1997)

Murck, H.; Frieboes, R.-M.; Schier, T.; Steiger, A.: Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects - a preliminary study. Pharmacopsychiatry 30, S. 122 - 124 (1997)

Neumann, I.: Antisense oligonucleotides in neuroendocrinology: enthusiasm and frustration. Neurochemistry International 31, S. 363 - 378 (1997)

Patchev, V. K.; Almeida, O. F. X.: Gender specificity in the neural regulation of the response to stress. Molecular Neurobiology 16, S. 56 - 80 (1997)

Patchev, V. K.; Montkowski, A.; Rouskova, D.; Koranyi, L.; Holsboer, F.; Almeida, O. F. X.: Neonatal treatment of rats with the neuroactive steroid tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. Journal of Clinical Investigation 99, S. 962 - 966 (1997)